This bill mandates the United States Postal Service (USPS) to continue selling the Alzheimer's semipostal stamp for an additional six-year period, starting from when sales would have otherwise ceased. This initiative aims to provide a convenient way for the public to contribute to funding medical research relating to Alzheimer's disease . All proceeds from the sale of these stamps will be transferred to the National Institutes of Health for this specific research purpose, with payments made at least twice annually. While generally governed by existing semipostal stamp regulations, the stamp's continued sale under this new section ensures its availability, potentially overriding previous limitations on concurrent semipostal stamp offerings.